Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Revenue

In the year 2025, Sinil Pharmaceutical had annual revenue of 80.56B KRW, down -9.92%. Sinil Pharmaceutical had revenue of 21.14B in the quarter ending December 31, 2025, a decrease of -1.90%.

• Revenue: 80.56B
• Revenue Growth: -9.92%
• P/S Ratio: 0.85
• Revenue / Employee: 280.71M
• Employees: 287
• Market Cap: 68.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	80.56B	-8.88B	-9.92%
Dec 31, 2024	89.44B	305.25M	0.34%
Dec 31, 2023	89.14B	9.13B	11.41%
Dec 31, 2022	80.01B	18.25B	29.56%
Dec 31, 2021	61.75B	316.13M	0.51%